Epstein, formerly CEO of Seagen, joins as Chair & Chief Executive Officer Mehdi Shahidi, previously SVP and Chief Medical Officer at Boehringer Ingelheim, joins as Head of Development & Chief Medical ...
The new pharma stepped into the light after three years of pre-clinical work and a 2025 filing goal for its lead candidate. (stalkerstudent/GettyImages) After ...
LONDON and BOSTON, Dec. 19, 2024 /PRNewswire/ -- Ottimo Pharma ("Ottimo"), a private biotech company pioneering bifunctional medicines to extend the lives of people living with cancer, today announces ...
Anglo-US biotech Ottimo Pharma has completed a big early-stage biotech financing, raising $140 million for its PD-1 and VEGF targeting drug jankistomig for cancer. The London and Boston-based start-up ...
SEOUL, South Korea, May 17, 2026 /PRNewswire/ -- LOTTE Biologics (Co-CEOs James Park and Yooyeol Shin) announce an expansion of its collaboration with Ottimo Pharma, an innovative biotech company ...
Dansey, a former senior executive at Pfizer and Seagen, Inc., brings extensive experience in immuno-oncology and drug development Board appointment reinforces Company's commitment to advancing ...
Financing led by OrbiMed, Avoro Capital, and Samsara BioCapital, with additional investment from founding investor Medicxi Strengthens its leadership team with the appointments of industry veterans ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results